Literature DB >> 1718854

In vivo effects of anti-idiotype on Plasmodium chabaudi infection in mice.

M J Moore1, F C Hay, J Wood, K N Brown.   

Abstract

A polyclonal anti-idiotype was raised in rabbits following immunization with a murine monoclonal antibody which recognized a 250,000 MW antigen of Plasmodium chabaudi-infected erythrocytes. The monoclonal antibody, NIMP M23 (clone 3,) has been shown to protect mice against homologous parasite challenge. Following purification, the anti-idiotype was shown to bind only the immunizing idiotype and to recognize antigen-binding site-associated anti-idiotype. Mice primed with anti-idiotype and challenged with live parasites had an altered course of infection, with significant reduction in their peak parasitaemia levels. Anti-idiotype priming did not induce an antigen-reactive antibody response in vivo but a population of T cells capable of proliferating in vitro to P. chaubaudi-infected red cells was stimulated. These data are discussed in the context of possible idiotypic interaction in murine malaria.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718854      PMCID: PMC1384667     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  Analysis of the permissive association of a malaria T cell epitope with DR molecules.

Authors:  J Kilgus; T Jardetzky; J C Gorga; A Trzeciak; D Gillessen; F Sinigaglia
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

2.  A hybrid gene to express protein epitopes from both sporozoite and merozoite surface antigens of Plasmodium falciparum.

Authors:  A A Holder; M J Lockyer; G W Hardy
Journal:  Parasitology       Date:  1988-12       Impact factor: 3.234

3.  Studies on anti-leishmania activity of immune rabbit serum.

Authors:  H R Rezai; N Behforouz; S Gettner
Journal:  J Parasitol       Date:  1970-04       Impact factor: 1.276

4.  Idiotypic networks and their possible exploitation for manipulation of the immune response.

Authors:  I M Roitt; A Cooke; D K Male; F C Hay; G Guarnotta; P M Lydyard; L P de Carvalho; Y Thanavala; J Ivanyi
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

5.  Isolation of cDNA clones encoding T cell-specific membrane-associated proteins.

Authors:  S M Hedrick; D I Cohen; E A Nielsen; M M Davis
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

6.  Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria.

Authors:  J C Sadoff; W R Ballou; L S Baron; W R Majarian; R N Brey; W T Hockmeyer; J F Young; S J Cryz; J Ou; G H Lowell
Journal:  Science       Date:  1988-04-15       Impact factor: 47.728

7.  Research toward malaria vaccines.

Authors:  L H Miller; R J Howard; R Carter; M F Good; V Nussenzweig; R S Nussenzweig
Journal:  Science       Date:  1986-12-12       Impact factor: 47.728

8.  Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine.

Authors:  M F Good; J A Berzofsky; W L Maloy; Y Hayashi; N Fujii; W T Hockmeyer; L H Miller
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

9.  Syngeneic monoclonal antiidiotype can induce cellular immunity to reovirus.

Authors:  A H Sharpe; G N Gaulton; K K McDade; B N Fields; M I Greene
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

10.  Direct interactions between B and T lymphocytes bearing complementary receptors.

Authors:  J P Tite; J Kaye; K M Saizawa; J Ming; M E Katz; L A Smith; C A Janeway
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

View more
  1 in total

1.  Differential requirement for cathepsin D for processing of the full length and C-terminal fragment of the malaria antigen MSP1.

Authors:  Calogero Tulone; Anne-Marit Sponaas; Eun-Ang Raiber; Alethea B Tabor; Jean Langhorne; Benny M Chain
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.